期刊文献+

角蛋白17上HLA-DRB1*07限制性T细胞表位的确定 被引量:4

Identification of HLA-DRB1*07-restricted T cell epitope on keratin 17
原文传递
导出
摘要 目的对银屑病自身抗原棗角蛋白17的HLA-DRB1*07限制性T细胞表位进行确定.方法在前期已确定角蛋白17的HLA-DRB1*07限制性T细胞表位区试验基础上,借助互联网服务器对其中的T细胞表位进行分析预测,人工合成T细胞表位DNA并进行GST融合表达和纯化;分离纯化外周血T细胞,将各融合表位肽段分别与正常人和银屑病患者的T细胞体外作用,检测T细胞增殖程度和培养上清中1FN-γ水平变化,从而筛选出强反应性表位.结果角蛋白17的S1(118-132)、S2(169-183)、S4(323-337)和S4(348-362)表位能够显著地促进银屑病患者T细胞增殖和IFN-γ分沁,与正常对照组比较差异有统计学意义(P均<0.001).结论 S1(118~132)(VRALEEANTELEVKI)、S2(169~183)(ANILLQIDNARLAAD)、S4(323~337)(MQALEIELQSOQLSMK)和S4(348~362)(ENRYCVQLSQIQGLI)是银屑病特异性强反应性HLA-DRB1*07限制性T细胞表位.本研究为以后研究银屑病的免疫发病机制和治疗打下了一定基础. Objective To identify the HIA-DRB1 * 07-restricted T cell epitopes on keratin 17 (K17), one of the autoantigens of psoriasis. Methods In the previous study we identified the HLA-DRB1 * 07-restricted T cell epitope regions on K17. Epitopes in the regions were predicted with interact servers in this study. The two nucleic acid strains of each predicted epitope with restriction endonuclease sites were synthesized and then expressed at N-temainus of GST. These recombinant epitopes and the level of T cell proliferation and the concentration of IFN-γ in the culture were detected. Results Compared with the control group and other epitopes, S1(118- 132), S2(169-183), S4(323-337) and S4(348-362) had a positive role on the proliferation and IFN-γ expression of T cells from psoriatic patients ( P 〈 0. 001 ). Conclusion The results indicated that epitopes S1 ( 118- 132)(VRALEEANTELEVKI), S2(169-183) (ANILLQIDNARLAAD) , S4(323-337)(MQALEIELQSQLSMK) and S4(348-362)(EMRYCVQLSQIQCLI) the psoriasis-specific HLA-DRB1 * 07-restricted T cell epitopes. The advanced study targeting to these peptides can provide a more complete understanding of the immunological basis of the disease.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2005年第10期790-793,共4页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(No.30371650) 第四军医大学优秀博士课题资助(No.2003004)
关键词 银屑病 角蛋白17 T细胞表位 HLA—DRB1*07 Psoriasis Keratin 17 T cell epitope
  • 相关文献

参考文献8

  • 1Chamian F, Krueger JG. Psoriasis vulgaris: an interplay of T lymphocytes dendritic cells, and inflammatory cytokines in pathogenesis. Curr Opin Rheumatol, 2004, 16(4): 331-337.
  • 2卢晓燕,冯晓玲,张卓华,那爱华,赵广,孔健.链球菌M6蛋白的纯化及其在银屑病患者血清检测中的应用[J].中华微生物学和免疫学杂志,2003,23(7):575-576. 被引量:1
  • 3Gudmundsdottir AS, Sigmundsdottir H, Sigurgeirsson B, et al. Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis? Clin Exp Immunol, 1999, 117(3) : 580-586.
  • 4沈柱,王刚,樊建勇,李巍,刘玉峰.人角蛋白17的HLA-DR限制性T细胞表位区的确定[J].中华微生物学和免疫学杂志,2004,24(10):769-772. 被引量:5
  • 5Oguz-Savran F, Diler A, Erzengin D, et al.HLA-DRB1 association in Turkish psoriasis vulgaris patients. Swiss Med Wkly, 2003, 133(39-40) :541-543.
  • 6Rammensee HG, Bachmann J, Emmerich NPN, et al. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics, 1999, 50(3-4) : 213-219.
  • 7Singh H, Aghava GPS. ProPred: Prediction of HLA-DR binding sites.Bioinformatics, 2001, 17(12): 1236-1237.
  • 8Cather J, Menter A. Novel therapies for psoriasis. Am J Clin Dermatol,2002, 3: 159-173.

二级参考文献5

共引文献4

同被引文献33

  • 1沈柱,王刚,樊建勇,李巍,刘玉峰.人角蛋白17的HLA-DR限制性T细胞表位区的确定[J].中华微生物学和免疫学杂志,2004,24(10):769-772. 被引量:5
  • 2沈柱,王刚,李巍,刘玉峰.角蛋白17对银屑病患者T细胞增殖和分泌干扰素γ的影响[J].中华皮肤科杂志,2004,37(11):659-661. 被引量:14
  • 3王刚,刘玉峰.治疗银屑病的一个新的药物作用靶标——角蛋白17[J].中国皮肤性病学杂志,2005,19(12):753-754. 被引量:8
  • 4Ghoreschi K, Rocken M. lmmunopathogenesis of psoriasis. J Dtsch Dermatol Ges, 2003, 1 ( 7 ) : 524-532.
  • 5Gudmundsdottir AS, Sigmundsdottir H, Sigurgeirsson B, et al. Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis? Clin Exp Immunol, 1999, 117 ( 3 ) : 580- 586.
  • 6Shen Z, Wang G, Fan JY, et al. HLA DR B1*04, *07-restricted epitopes on keratin 17 for autoreactive T cells in psoriasis. J Dermatol Sci, 2005, 38( 1 ): 25-39.
  • 7Bockelmann R, Horn T, Gollnick H, et al. Interferon-gammadependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: exploration of pharmaco- and gene-therapeutic effects. Skin Pharmacol Physiol, 2005, 8 ( 1 ) : 42-54.
  • 8Shen Z, Chen L, Wang G, et al. Reply: Keratin 17/interferon-γ autoimmune loop as a vicious circle driving psoriasis pathogenesis. J Am Acad Dermatol, 2007, 56 ( 1 ): 162-164.
  • 9Kalergis AM, Nathenson SG. Altered peptide ligand-mediated TCR antagonism can be modulated by a change in a single amino acid residue within the CDR3 beta of an MHC class Ⅰ- restricted TCR. J Immunol, 2000, 165 ( 1 ): 280-285.
  • 10Paas-Rozner M, Sela M, Mozes E. A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells. Proc Natl Acad Sci U S A, 2003, 100( 11 ): 6676-6681.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部